Skip to main content
SpringerLink
Log in

Spontaneous Resolution of Congenital Hyperinsulinism With Octreotide Therapy

  • Clinical Case Letters
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Galcheva S, Demirbilek H, Al-Khawaga S, Hussain K. The genetic and molecular mechanisms of congenital hyper-insulinism. Front Endocrinol. 2019;10:111.

    Article  Google Scholar 

  2. Mohnike K, Weiland L, Barthlem W, Vogelgesang S, Empting S, Mohnike W, et al. Clinical and genetic evaluation of patients with KATP channel mutations from the German registry for congenital hyperinsulism. Horm Res Paediatr. 2014;81:156–68.

    Article  CAS  Google Scholar 

  3. Suchi M, Mac Mullen CM, Thornton PS, Adzick NS, Ganguly A, Ruchelli ED, et al. Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism. Mod Pathol. 2006;19:122–9.

    Article  CAS  Google Scholar 

  4. Snider KE, Becker S, Bayajian L, Shyng SL, MacMullan C, Hughes N, et al. Genotype and phenotype correlatios in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metob. 2013;98:E355–63.

    Article  CAS  Google Scholar 

  5. Yorifuji TI, Hosokawa Y, Fujimaru R, Kawakita R, Doi H, Matsumoto T, et al. Lasting 18F-DOPA PET uptake after clinical remission of the focal form of congenital hyperinsulinism. Horm Res Paediatr. 2011;76:286–90.

    Article  CAS  Google Scholar 

  6. Katz MD, Erstad BL. Octreotide, a new somatostatin analogue. Clin Pharm. 1989;8:255–73.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Dr Sara E Flanagan PhD, Sir Henry Dale Fellow, Genetic laboratory services, University of Exeter Medical School, United Kingdom for the genetic study and assistance with the preparation of the manuscript. Dr Eddy Saputra Leman, PhD, Sr Scientific Editor, Duke-NUS Medical School, Singapore and Prof Divakaran Liginlal (Carnegie Mellon University, Pittsburgh, Pennsylvania) for editing the manuscript.

Author information

Authors and Affiliations

  1. Departments of Neonatology, KK Womens and Childrens Hospital, Singapore, Singapore

    Suresh Chandran

  2. Children’s Hospital, Mandalay, Myanmar

    Wai Lin Tun & Phyo Thandar Htay

  3. Pediatric Endocrinology, Sidra Medicine, Doha, Qatar

    Khalid Hussain

Authors
  1. Suresh Chandran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wai Lin Tun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Phyo Thandar Htay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Khalid Hussain
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Contributors: SC: clinical management, reviewed and edited the manuscript; WLT and PTH: patient management, outline of the case report and discussion; KH: contributed to the genetic section of the case report and reviewed and finalized the manuscript.

Corresponding author

Correspondence to Suresh Chandran.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chandran, S., Tun, W.L., Htay, P.T. et al. Spontaneous Resolution of Congenital Hyperinsulinism With Octreotide Therapy. Indian Pediatr 57, 474–475 (2020). https://doi.org/10.1007/s13312-020-1829-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-020-1829-3

Search

Navigation